Cited by 52Ovarian function and disordersEndometriosis Research and TreatmentDiabetes, Cardiovascular Risks, and Lipoproteins

Global burden of polycystic ovary syndrome among women of childbearing age, 1990–2021: a systematic analysis using the global burden of disease study 2021

Open access
Meng, Yaping, Zhao, Ting, Zhang, Rui, Zhu, Xiaoyan, Ma, Chao, Shi, Qin·2025·Frontiers in Public Health

Abstract

Background: The escalating global incidence of polycystic ovary syndrome (PCOS) necessitates a thorough examination of its epidemiological trends and sociodemographic correlations. Our study bridges this gap by analyzing the global impact of PCOS among women of childbearing age (WCBA) from 1990 to 2021, aiming to inform strategies for enhanced prevention and management. Methods: We extracted data from the Global Burden of Disease Study 2021 (GBD 2021), focusing on the burden of PCOS among women aged 15–49 years. We assessed incidence, prevalence, and disability-adjusted life years (DALYs) trends using the estimated annual percentage change (EAPC) and explored the link between PCOS burden and sociodemographic index (SDI). Results: In 2021, the prevalence cases of PCOS worldwide were 65.77 million, the incidence cases were 1,175.07 thousand, and the DALYs cases were 576.05 thousand. Compared with 1990, the percentage changes were 89, 49, and 87%, respectively. The EAPCs indicated upward trends in prevalence and DALYs rates, with a less pronounced increase in incidence rates. The middle SDI region had the highest PCOS case numbers, and the 45–49 age group in this region experienced the most significant burden increase. A strong positive correlation existed between PCOS prevalent rates and SDI ( r = 0.582, p < 0.001). Conclusion: The global burden of PCOS among WCBA has significantly increased over the past three decades, particularly in the 45–49 age group in middle SDI regions. The correlation between PCOS prevalent rates and SDI highlights the role of socio-economic factors in PCOS epidemiology. Tailored prevention and management strategies are crucial for reducing the global burden of PCOS and improving female health outcomes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fpubh.2025.1514250

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The prevalence of PCOS in this cohort (approximately 29%) is equivalent to the prevalence reported in India and Bangladesh (ranging between 20% and 33% based on the criterion used).

    “The prevalence of approximately 29% of this cohort is equivalent to the prevalence reported in India and Bangladesh (ranging between 20% and 33% based on the criterion used [4]) is.”

    From Prevalence of Polycystic Ovary Syndrome (PCOS) and Its Association with Metabolic Syndrome in Reproductive-Aged Women: A Cross-Sectional Study (2025) · cites this paper as [4]

    The Discussion (page not available) says PCOS prevalence varies with diagnostic criteria, supporting that part of the cited statement. It does not report a 20%–33% prevalence range for India and Bangladesh, so the country-specific comparison with this cohort is unsupported. (LLM, conf=0.83)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Meng, Y., Zhao, T., Zhang, R., Zhu, X., Ma, C., & Shi, Q.
Affiliations
  • Jiading District Central Hospital (CN)
  • Weifang Medical University (CN)
Corresponding author
  • Ma, Chao
  • Shi, Qin
Venue
Frontiers in Public Health
Published
2025-03-26
Volume
13
Pages
1514250-1514250
ISSN
2296-2565 (ISSN-L)
OpenAlex
W4408841161
Cited by
43
References
36
Citations by year
2026: 27 · 2025: 16
FWCI
37.73
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Public Health (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
polycystic ovary syndrome, women of reproductive age, global burden of disease, disability-adjusted life years, prevalence trends, incidence trends, socio-demographic index, socioeconomic factors, reproductive health
MeSH terms
Global Burden of Disease, Disability-Adjusted Life Years, Adolescent, Adult, Female, Humans, Middle Aged, Polycystic Ovary Syndrome, Socioeconomic Factors, Global Health, Incidence, Prevalence, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review